Physician profile
Albert Park
NPI 1013565324
$2,045.31
in general payments reported to CMS, 2019-2025
6 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20.61 · 2020: $21.10 · 2023: $1,964 · 2024: $39.25.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,058 · Food and Beverage: $946.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,058.01 |
| Food and Beverage | $945.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dentsply Sirona INC | $962.50 | 2023 | |
| Patterson Companies, INC. | $832.16 | 2023-2024 | |
| Zimvie INC. | $128.04 | 2023 | |
| Nobel Biocare USA | $60.39 | 2023 | Nobelactive |
| Orapharma, A Division of Bausch Health US, LLC | $41.71 | 2019-2020 | |
| Envista Holdings Corporation | $20.51 | 2024 | Spark |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Albert Park listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.